COVID 19 Detection Kits Market
- Published Date: Aug-2021 |
- 180 Pages |
- Report ID: MD1024
COVID 19 Detection Kits Market
COVID-19 Detection Kits market is expected to grow from USD 48.80 billion in 2019 to USD 215.42 billion by 2026 at a CAGR of 23.63% from 2020 to 2026.
Increasing incidence of COVID-19 worldwide and difficulty in containing the spread will foster these kits' demand. Technological progress and consequent development of advanced coronavirus diagnostic kits also will trigger the market growth over the forthcoming years. Transmission of the virus occurs quickly through direct contact with an infected person and indirect contact with surfaces within the immediate environment. This has increased the necessity for COVID-19 detection kits. This is attributing increasing incidences of COVID-19 and rising geriatric population globally. consistent with the planet Health Organization, COVID- 19 outbreak declared as an epidemic due to the worldwide spread and severity of diseases.
Furthermore, the geriatric population is more susceptible to acquire this disease due to low immunity levels thus these populations are considered at greater risk of catching coronavirus disease. Moreover, the increasing government & several major player initiatives around the world to deliver much-needed test assays for the detection and diagnosis of COVID-19 will end in propelling the general market. A vital testament for the aforementioned statement is often provided by Hologic''s recent announcement of receiving hefty funds from the Biomedical Advanced Research and Development Authority. This fund is predicted to support the corporate in scaling up its COVID-19 detection kits production. The global market is segregated on the basis of Product as RT-PCR assay kits and Immunoassay test strips/cassettes. Based on Specimen Type the global market is segmented in Nasopharyngeal swab, Oropharyngeal swab, Nasal swab, and Others. Based on End-Use the global market is segmented in Hospitals, Diagnostic Centers, and Others.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott Laboratories, BGI, BioFire Diagnostics, Cepheid, Co-Diagnostics, F. Hoffmann-La Roche, GenMark Diagnostics, Guangzhou Wondfo Biotech, Mylab Discovery Solutions, Qiagen, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global COVID-19 Detection Kits market has been segmented as below:
By Product
- RT-PCR assay kits
- Immunoassay test strips/cassettes
By Specimen Type
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Others
By End-Use
- Hospitals
- Diagnostic centers
- Others
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
By Company
- Abbott Laboratories
- BGI
- BioFire Diagnostics
- Cepheid
- Co-Diagnostics
- Hoffmann-La Roche
- GenMark Diagnostics
- Guangzhou Wondfo Biotech
- Mylab Discovery Solutions
- Qiagen
The report covers the below scope:
- Global market sizes from 2019 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2021 to 2026
- Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
- Comprehensive company profiles of the key industry players
The years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2020
- Projected year - 2021
- Forecast period - 2021 to 2026
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Abbott Laboratories, BGI, BioFire Diagnostics, Cepheid, Co-Diagnostics, F. Hoffmann-La Roche, GenMark Diagnostics, Guangzhou Wondfo Biotech, Mylab Discovery Solutions, Qiagen, and others.
Why to Buy this Report:
- Gain detailed insights on the COVID-19 Detection Kits industry trends
- Find a complete analysis of the market status
- Identify the market opportunities and growth segments
- Analyze competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Target Audience:
The report targeted the existing players in the industry is as follows:
- Market Manufacturers/Service Providers
- Market Wholesale/Traders
- Investment and Financial Institutions
Free and Paid Customization based on the requirement
Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
- COVID-19 Detection Kits Market, By Product
5.1 Introduction
5.2 RT-PCR assay kits
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Immunoassay test strips/cassettes
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- COVID-19 Detection Kits Market, By Specimen Type
6.1 Introduction
6.2 Nasopharyngeal swab
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Oropharyngeal swab
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Nasal swab
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- COVID-19 Detection Kits Market, By End Use
7.1 Introduction
7.2 Hospitals
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Diagnostic centers
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Others
7.4.1 Market Overview
7.4.2 Market Size and Forecast
- COVID-19 Detection Kits Market, By Geography
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Product
8.2.2 Europe Market, By Specimen Type
8.2.3 Europe Market, By End Use
8.3 North America
8.3.1 North America Market, By Product
8.3.2 North America Market, By Specimen Type
8.3.3 North America Market, By End Use
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Product
8.4.2 Asia Pacific Market, By Specimen Type
8.4.3 Asia Pacific Market, By End Use
8.5 Rest of The World
8.5.1 Rest of The WorldMarket, By Product
8.5.2 Rest of The World Market, By Specimen Type
8.5.3 Rest of The World Market, By End Use
- Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
- Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 BGI
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 BioFire Diagnostics
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Cepheid
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Co-Diagnostics
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 F. Hoffmann-La Roche
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 GenMark Diagnostics
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Guangzhou Wondfo Biotech
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Mylab Discovery Solutions
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Qiagen
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The global COVID-19 Detection Kits market has been segmented as below:
By Product
- RT-PCR assay kits
- Immunoassay test strips/cassettes
By Specimen Type
- Nasopharyngeal swab
- Oropharyngeal swab
- Nasal swab
- Others
By End Use
- Hospitals
- Diagnostic centers
- Others
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
By Company
- Abbott Laboratories
- BGI
- BioFire Diagnostics
- Cepheid
- Co-Diagnostics
- Hoffmann-La Roche
- GenMark Diagnostics
- Guangzhou Wondfo Biotech
- Mylab Discovery Solutions
- Qiagen